Copyright
©The Author(s) 2018.
World J Gastroenterol. Jun 7, 2018; 24(21): 2311-2319
Published online Jun 7, 2018. doi: 10.3748/wjg.v24.i21.2311
Published online Jun 7, 2018. doi: 10.3748/wjg.v24.i21.2311
Table 4 Summary of findings
Outcomes | Intervention values | Control values | Number of patients | Quality of evidence (GRADE) | Comments |
PDI | 0.335/mo | 1.355/mo | 121 | Very low | Only studies with cross-over design were analyzed |
MD: -1.12 | |||||
95%CI: -1.99 to -0.25 | |||||
P = 0.012 | |||||
TNRD | n/a | n/a | 165 | Very low | Different length of follow up results in high risk of bias |
MD: -1.17 | |||||
95%CI: -0.24 to 0.05 | |||||
P = 0.057 | |||||
DS | n/a | n/a | 178 | Very low | Different scoring scales were used and different lengths of follow up result in high risk of bias |
SMD: 0.35 | |||||
95%CI: -0.38 to 1.08 | |||||
P = 0.351 |
- Citation: Szapáry L, Tinusz B, Farkas N, Márta K, Szakó L, Meczker Á, Hágendorn R, Bajor J, Vincze Á, Gyöngyi Z, Mikó A, Csupor D, Hegyi P, Erőss B. Intralesional steroid is beneficial in benign refractory esophageal strictures: A meta-analysis. World J Gastroenterol 2018; 24(21): 2311-2319
- URL: https://www.wjgnet.com/1007-9327/full/v24/i21/2311.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i21.2311